Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-28

Clinical Trial Update: Autologous Natural Killer T Cells Infusion for the Treatment of Cancer [NA]

View source ↗

Summary

Clinical trial update on autologous natural killer T cell infusion for cancer with unknown status at this time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous natural killer T cells infusion

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Breast Cancer, Glioma | NA | Status: UNKNOWN